REVELATION BIOSCIENCES, INC. Proceeds from Notes Payable
REVELATION BIOSCIENCES, INC. (REVB) reported Proceeds from Notes Payable of $750.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-04-15
- REVELATION BIOSCIENCES, INC. proceeds from notes payable for the quarter ending 2020-12-31 was $0.00.
- REVELATION BIOSCIENCES, INC. proceeds from notes payable for fiscal 2021 was $750.00K, a 435.71% increase from fiscal 2020.
- REVELATION BIOSCIENCES, INC. proceeds from notes payable for fiscal 2020 was $140.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2021-12-31 | $750.00K 10-K · filed 2022-04-15 | ||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-06-16 | $140.00K 10-K/A · filed 2021-06-16 | |
| 2020-09-30 | $140.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |